Here is a report of a single patient treated with EPO, a widely prescribed drug for treatment of anemia. It appears to confirm the computer-modeled hypothesis for a mechanism of action for CoV-2 virus involving hemoglobin in red blood cells. Obviously, a single anecdotal report from the clinic is not sufficient testing.
J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25839. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/?term=32270515&fbclid=IwAR3J-mRAHKIffEaJL_udP_LT1uIT9HrkGXYg1PlE3EOqGLuh_KaI84CGxa4
Like this:
Like Loading...
About budbromley
Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.
budbromley 